News

A randomised clinical trial shows that the SMART-CP boosts rehab access for Bangladeshi children with cerebral palsy.

A new study shows that prothrombin complex concentrate (PCC) offers superior bleeding control and fewer complications than frozen plasma in cardiac surgery patients.

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.

Mental health concerns were prevalent, with nearly all families experiencing stress.

A study at EBMT 2025 shows improved outcomes for relapsed lymphoma patients using CAR-T cell therapy with stem cell transplantation.

HSCT shows promising results as a cure for very early-onset inflammatory bowel disease caused by IL-10 receptor deficiency.

Recent studies have identified a gene signature known as the senescent hepatocyte gene signature that tracks with MASLD progression.

Explore EBMT 2025 results on transplantation outcomes for Myelodysplastic Syndrome and Acute Myeloid Leukaemia, highlighting survival and relapse data.